All News about Cel-Sci Corp
![](https://mms.businesswire.com/media/20220527005092/en/226967/5/CEL-SCI_Logo.jpg)
CEL-SCI Announces Publication of ASCO 2022 Abstracts
May 27, 2022
From CEL-SCI Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20220516005179/en/226967/5/CEL-SCI_Logo.jpg)
![](https://mms.businesswire.com/media/20220422005364/en/226967/5/CEL-SCI_Logo.jpg)
CEL-SCI Announces Acceptance of Abstracts to ASCO 2022
April 22, 2022
From CEL-SCI Corporation
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/mid-day_movers_image.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/21/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/mid-day_movers_image_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/18/mid-day_movers_image.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/yesterdays_movers.png)
![](https://mms.businesswire.com/media/20220214005134/en/226967/5/CEL-SCI_Logo.jpg)
CEL-SCI Corporation Reports First Quarter Fiscal 2022 Financial Results
February 14, 2022
From CEL-SCI Corporation
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6442.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/valuestock_image_11.jpeg)
![](https://mms.businesswire.com/media/20211222005097/en/226967/5/CEL-SCI_Logo.jpg)
CEL-SCI Reports Fiscal 2021 Financial Results and Clinical & Corporate Developments
December 22, 2021
From CEL-SCI Corporation
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://mms.businesswire.com/media/20211022005045/en/226967/5/CEL-SCI_Logo.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/stock-1863880_1920_196.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day-market-update_7.jpg)
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
August 17, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://mms.businesswire.com/media/20210816005105/en/226967/5/CEL-SCI_Logo.jpg)
From CEL-SCI Corporation
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/632961/scientists-looking-at-monitor-in-lab.jpg)
![](https://mms.businesswire.com/media/20210707005476/en/226967/5/CEL-SCI_Logo.jpg)
CEL-SCI Corporation Issues Letter to Shareholders
July 07, 2021
From CEL-SCI Corporation
Via Business Wire
![](https://g.foolcdn.com/editorial/images/632468/gettyimages-1214903198.jpg)
![](https://mms.businesswire.com/media/20210702005311/en/226967/5/CEL-SCI_Logo.jpg)
From CEL-SCI Corporation
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.